307 S. Jackson

We are currently participating in a nationwide clinical trial, HARBOR, sponsored by Genentech, Inc for evaluating a new investigational treatment for wet age-related macular degeneration. It is currently closed for new participants. Any results from this study will be made public as soon as they become available.